Clinical Study
Improved Outcomes with Intensity Modulated Radiation Therapy Combined with Temozolomide for Newly Diagnosed Glioblastoma Multiforme
Table 1
Patient demographics.
| | | (Percentage) |
| | Age (years) | | | | Median | 63.9 | | Range | 30.7–89.2 | | Gender | | | | Male |
21 (67.7) | | Female | 10 |
| | | 40.05 Gray | 60 Gray |
| | Functional status | | | | ECOG 0 | 2 (16.67%) | 7 (36.9%) | | ECOG 1 | 8 (66.66%) | 12 (63.1%) | | ECOG 2 | 2 (16.67%) | 0 |
| | Surgery | | | | Biopsy/unknown | 4 (12.9) | | Subtotal resection | 9 (29) | | Gross total resection | 18 (58.1) |
| | | Concurrent TMZ | Adjuvant TMZ |
| | 60 Gray () | 18 | 18 | | 40.05 Gray () | 5 | 5 |
|
|
